Pfizer seeks U.S. authorization of COVID-19 booster shots for 16, 17 year olds

Reuters2021-12-01

Nov 30 (Reuters) - Pfizer Inc's Chief Executive Officer Albert Bourla said on Tuesday the company has submitted a request to the U.S. Food and Drug Administration seeking the authorization for its COVID-19 booster doses for use in 16- and 17-year olds.

Last week, U.S. regulators expanded the eligibility for a booster dose of Pfizer and partner BioNTech's vaccine to all adults 18 and over, to be given at least six months after the second shot.

If given the go-ahead, Pfizer's booster vaccine will be the first to be cleared for use in the younger age group.

The Wall Street Journal reported on Monday that the FDA could approve Pfizer's booster doses for 16- and 17-year olds as soon as next week.

U.S. government and the country's health regulators are currently pushing for wider vaccinations to prevent the spread of the highly infectious Omicron coronavirus variant, which was first detected in southern Africa.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • ferwih
    2021-12-01
    ferwih
    Nice info
  • PG123
    2021-12-01
    PG123
    Like
  • 987ce65
    2021-12-01
    987ce65
    Great ariticle, would you like to share it?
  • MHh
    2021-12-01
    MHh
    Get whatever profit possible first until new vaccine gets developed. And even with new vaccine developed, if this is approved, more of these 16,17 year olds will still have to get this until the new one is approved for them…
  • jolynnnnnnnn
    2021-12-01
    jolynnnnnnnn
    No way
发表看法
5